Connect with us

Technology

HKA expands its Intellectual Property practice with the appointment of Michael J. Lasinski as Partner

Published

on

LONDON and PHILADELPHIA, April 7, 2025 /PRNewswire/ — HKA is pleased to announce the appointment of Michael J. Lasinski as a Partner and expert consultant on the financial aspects of intellectual property (IP) and commercial disputes. With over 30 years of experience, Mike brings a wealth of knowledge and expertise to the firm’s IP practice.

Mike is a recognized leader in SEP licensing, willing licensor and licensee analysis, and FRAND economic analyses.

Mike has been appointed as an expert on hundreds of engagements, providing invaluable insights into transactions, valuations, and damages analyses. He has testified in various prestigious courts, including U.S. District Courts, the International Trade Commission, the High Court of Justice of England and Wales, the Chancery Division, state courts, and arbitration proceedings.

Mike is a recognized leader in standard essential patent licensing, willing licensor and licensee analysis, and fair, reasonable, and non-discriminatory (FRAND) economic analyses. He has performed licensing and FRAND analysis for cellular, Wi-Fi, video and audio codecs, streaming, and many other standards. Mike has been both a licensing advisor and named expert on dozens of matters concerning standards and FRAND licensing practice and FRAND determination.

Throughout his career, Mike has conducted economic analyses for patent, trademark, trade dress, trade secret, data privacy, breach of contract, and many other commercial damages matters. He has served as a financial advisor to creditor committees, private equity companies, venture capitalists, and Fortune 500 companies on numerous occasions. Notably, he played a key role in advising creditors and other interested parties on IP and financial issues related to the more than $4.5 billion sale of Nortel’s patent portfolio.

Mike’s experience also extends to acquisitions, divestitures, mergers, joint ventures, and bankruptcy. Prior to joining HKA, he was head of analysis at Hilco Intellectual Property Merchant Banking and senior managing director and head of the IP practice at Ankura Consulting Group. He was also a founding member of 284 Partners, LLC, a professional services firm focused on IP valuation, litigation consulting, IP strategy, and transactional services.

Mike’s consulting experience spans various industries, including advertising, automotive, chemicals, computer hardware and software, consumer products, e-commerce, food and beverage, internet, internet of things (IoT), healthcare, life sciences, medical devices, pharmaceuticals, semiconductors, streaming, telecommunications, and wireless communications. He has assisted clients in strategically managing their IP by creating global corporate organizations designed to maximize their current and future value.

Mike is a Certified Public Accountant, Certified in Financial Forensics, and a Certified Licensing Professional. Most recently, he served as the president of the Licensing Executives Society International. Mike is a member of the American Institute of Certified Public Accountants and the Illinois Chartered Public Accountant Society. He has lectured on IP valuation for university business schools, law schools, the United States Patent and Trademark Office, and other regulatory agencies.

Michael J. Lasinski commented on his new role: “I am thrilled to join HKA as a Partner. The firm’s commitment to excellence and client service delivery aligns perfectly with my professional values. Throughout my career, I have always strived to provide the highest level of expertise and support to my clients, and I am excited to continue this journey with HKA. I look forward to contributing to the growth of the firm’s intellectual property practice and working with a team of dedicated professionals to achieve successful outcomes for our clients.”

Paul K. Meyer, Partner, Joint FACD and Global IP Lead, Americas at HKA, added, “We are delighted to welcome Mike to our team. His extensive experience in providing insights into transactions, valuations, and damages analyses in intellectual property will be invaluable to our clients. I first met Mike nearly 15 years ago when we were providing licensing economics consulting for a joint defense group in an important IP matter. Mike was a pioneer in offering FRAND royalty evidence during the Unwired Planet v. Huawei trial in the UK High Court system. An accomplished testifying expert, he has covered a wide range of disputes, from FRAND to patent damages, having worked on some of the largest intellectual property disputes globally. His appointment underscores HKA’s commitment to providing top-tier consulting services in the fields of intellectual property valuation and commercial disputes.”

View Jeff’s full expert profile: https://www.hka.com/expert-post/michael-j-lasinski/.

HKA’s intellectual property experts offer specialized dispute services across the spectrum of IP practice. These services range from valuing intangible assets, quantifying damages, including lost profits and reasonable royalties, preparing accounts of the infringer’s profits, assisting with technology transfers and providing expert witness testimony.

Learn more about HKA’s Intellectual Property expert services.

ABOUT HKA

HKA is the leading global consultancy in risk mitigation, dispute resolution, expert witness, and litigation support services.

HKA brings a proud record of excellent service and high achievement to bear on today’s challenges. As trusted independent consultants, experts, and advisors, we help clients manage disputes, risk, and uncertainty on complex contracts and challenging projects. Our advice is impartial, incisive, and authoritative.

We work with government agencies, local authorities, contractors, legal firms, and other professional service providers, as well as owners and operators, financial institutions, and insurers. HKA’s global portfolio includes some of the world’s largest and most prestigious commissions across a wide range of industries.

HKA has in excess of 1,000 experts, consultants, and advisors across 45+ offices in 17 countries with the skills and experience that are essential to get to the heart of even the most complex issues.

For more information about HKA, visit hka.com and connect with us on LinkedIn, X (formerly Twitter, @HKAGlobal), and Facebook.

Media contact
Andrew J. Katz, CPSM
Marketing and Communications Director, Americas
+1 215 962 1136
andrewkatz@hka.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/hka-expands-its-intellectual-property-practice-with-the-appointment-of-michael-j-lasinski-as-partner-302422210.html

SOURCE HKA Global

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING

Published

on

By

NEW YORK, May 5, 2026 /PRNewswire/ — Vernal Capital Acquisition Corp. (NYSE: VECA) (“Vernal”) announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at $10.00 per unit. The units are expected to trade on the New York Stock Exchange (“NYSE”) under “VECAU” beginning May 6, 2026. Each unit consists of one ordinary share and one right to receive one-fourth of one ordinary share upon consummation of an initial business combination. Upon separate trading, the ordinary shares and rights are expected to be listed on NYSE under “VECA” and “VECAR,” respectively.

D. Boral Capital LLC is acting as sole book-running manager of the offering. The underwriters have a 45-day option to purchase up to 1,500,000 additional units to cover any over-allotments. The offering is expected to close on May 7, 2026, subject to customary closing conditions.

A registration statement for these securities was declared effective by the SEC on May 5, 2026. The offering is made only by means of a prospectus. Copies of the prospectus may be obtained, from D. Boral Capital LLC, 590 Madison Ave., 39th Floor, New York, New York 10022, by telephone at (212) 970-5150 or by email at dbccapitalmarkets@dboralcapital.com.

This press release shall not constitute an offer to sell or to buy, nor shall there be any sale where such offer, solicitation or sale would be unlawful prior to registration or qualification under the applicable securities laws.

About Vernal

Vernal is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Vernal’s target search will not be limited to a particular industry or geographic region.

Forward-Looking Statements

This press release contains “forward-looking statements,” including statements regarding Vernal’s IPO. These statements are subject to risks and uncertainties that could cause actual results to differ materially. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, beyond Vernal’s control, including those in the Risk Factors section of Vernal’s registration statement filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Vernal disclaims any obligation to release publicly updates or revisions to any forward-looking statements to reflect any change in Vernal’s expectations, except as required by law.

Contact

Binghan Yi, CFO
binghan@vernal.com
www.vernalspac.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vernal-capital-acquisition-corp-announces-pricing-of-100-million-initial-public-offering-302763378.html

SOURCE Vernal Capital Acquisition Corp.

Continue Reading

Technology

RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America

Published

on

By

Nomination places the Charlottesville-based company among growth-stage medtech leaders recognized for commercial momentum in AI-powered clinical decision support; public voting is open through May 8

CHARLOTTESVILLE, Va., May 5, 2026 /PRNewswire/ — RIVANNA®, developer of AI-powered clinical decision-support solutions, today announced that it has been nominated for MedTech Scale-Up of the Year at the MedTech World Awards 2026 | North America. Public voting is open through Friday, May 8, 2026, with category winners to be announced at the inaugural North American Awards Gala on May 11, 2026, at the Hilton West Palm Beach in Florida.

The MedTech Scale-Up of the Year category honors a growth-stage company successfully scaling revenues, partnerships, and adoption across the global medical technology ecosystem. Nominees across the program’s 22 categories were selected through a structured process led by the MedTech World Steering Committee, with category winners determined by a combination of expert evaluation and public voting from the global MedTech community.

“We have built RIVANNA on validation earned from the most rigorous technical buyers in healthcare: competitive federal awards translated into FDA-cleared products, each paired with a commercial program that meets clinicians where they work,” said Will Mauldin, PhD, Co-founder and CEO of RIVANNA. “Being nominated for MedTech Scale-Up of the Year is a meaningful affirmation of that approach and the team executing it.”

Public voting closes Friday, May 8, 2026. Members of the MedTech community are invited to support RIVANNA’s nomination at the official voting page: vote here.

The award nomination follows a year of measurable scaling for RIVANNA:

In October 2025, RIVANNA reported on being named a finalist in MedTech Innovator’s 2025 Early-Stage Grand Prize competition, selected from nearly 1,500 global applicants to represent the top 4% of medtech innovations worldwide.In December 2025, RIVANNA reported on the U.S. Food and Drug Administration’s 510(k) clearance of its Accuro® 3S Needle Guide Kit consumables, building on existing Accuro 3S device clearance.In April 2026, RIVANNA reported on peer-reviewed findings, published in 2025 in the Journal of Emergency Medicine (DOI: 10.1016/j.jemermed.2025.11.011), showing that the Accuro® XV musculoskeletal imaging system enables non-physician operators to acquire diagnostic-quality scans after just one hour of hands-on training.In May 2026, RIVANNA reported on the U.S. Food and Drug Administration’s 510(k) clearance of the Accuro® XV Diagnostic Ultrasound System for musculoskeletal imaging, authorizing commercial use across hospital and clinic settings.The company’s clinical program now spans eight sites nationwide with more than 1,500 patients enrolled.

The 2026 MedTech World Awards | North America, powered by Blue Goat Cyber, will be presented Monday, May 11, 2026, at the inaugural North American Awards Gala at the Hilton West Palm Beach, marking the first time the MedTech World Awards have been hosted in the United States.

About the MedTech Scale-Up of the Year Award
Presented by MedTech World, the MedTech Scale-Up of the Year category recognizes growth-stage medical technology companies demonstrating strong commercial momentum, expanding partnerships, and accelerating real-world adoption. The award is one of 22 categories spanning innovation, clinical excellence, regulatory strategy, investment, and leadership across the global MedTech ecosystem.

About RIVANNA
RIVANNA® is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company’s platform automates complex anatomical analysis at the point of care, enabling faster, more confident clinical decisions while reducing variability and expanding access to advanced capabilities. The first applications target significant market opportunities in regional anesthesia and fracture care. RIVANNA has built a proven FDA regulatory track record across its Accuro® platform, with device clearances for Accuro® 3S (spinal needle guidance) and Accuro® XV (musculoskeletal imaging), a portfolio of supporting cleared consumables, and AI software modules advancing through regulatory review. The company is backed by 100+ patents and validated through clinical partnerships with leading academic medical centers. RIVANNA is headquartered in Charlottesville, Virginia, and operates an FDA-registered, ISO 13485:2016-certified manufacturing facility. Learn more at rivannamedical.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rivanna-nominated-for-medtech-scale-up-of-the-year-at-medtech-world-awards-2026–north-america-302763342.html

SOURCE RIVANNA

Continue Reading

Technology

D2L Launch Week Highlights Latest Product Releases

Published

on

By

Latest innovations are designed to save time, simplify workflows, and help drive better learning outcomes

TORONTO, May 5, 2026 /PRNewswire/ – D2L, a global leader in learning innovation, hosted its first-ever D2L Launch Week, a four-day virtual webinar series spotlighting the company’s latest product innovations across D2L Brightspace in 2026.

Throughout the week, D2L showcased a range of product releases through live demos and practical customer use cases, highlighting how institutions, school districts and organizations can help to drive engagement and improve learning outcomes. The featured updates include enhancements to D2L Lumi for idea generation, intervention suggestions, quiz creation and summarization; tools to strengthen parent and guardian outreach; and administrative capabilities designed to help large organizations delegate course and configuration management more effectively.

“We’re proud to showcase the ways D2L continues to innovate to help make learning more personalized, efficient, and scalable,” said Christian Pantel, Chief Product Officer at D2L. “From new D2L Lumi features to enhanced communication tools and more flexible distributed administration capabilities, these updates are designed to help our customers save time, improve usability, and deliver better learning experiences at scale.”

Enhancements to D2L Lumi

Among the new capabilities were several updates to D2L’s AI-native tool, D2L Lumi, designed to improve usability, transparency, and alignment across workflows, including:

D2L Lumi Ideas: Generates assignment and discussion ideas directly within Brightspace, making it easier to generate high quality content aligned to learning outcomes.D2L Lumi Insights: Gives educators access to learning intervention suggestions, designed to provide recommended next steps based on learner data.D2L Lumi Quiz: Helps educators generate questions from multiple course content topics and includes a more streamlined question-generation workflow.D2L Lumi Summary: Supports summarization from more content sources, including nested submodules, and can give educators the ability to preview and adjust source text before summarization.

Updates to Parent and Guardian Communications

D2L also introduced new parent and guardian communication enhancements to help K-12 educators strengthen engagement beyond the classroom. Teachers can now send bulk emails to all parents and guardians associated with students in their class. For individual student outreach, teachers can also email parents and guardians of a specific learner, making it easier to share timely updates on student progress and classroom activity.

Manage Distributed Administration at Scale

Distributed Administration gives organizations more flexibility to delegate administrative responsibilities across organization levels. With Distributed Administration, administrators can manage specific areas, enabling them to oversee courses while helping to reduce bottlenecks and free up time.

Learn more about the latest product releases showcased at D2L Launch Week.

About D2L   
D2L is transforming the way the world learns, helping learners achieve more than they dreamed possible. Working closely with customers all over the world, D2L is on a mission to make learning more inspiring, engaging and human. Find out how D2L helps transform lives and delivers outstanding learning outcomes in K-12, higher education and businesses.

D2L Media Contact
PR@D2L.com
X: @D2L
© 2026 D2L Corporation.

The D2L family of companies includes D2L Inc., D2L Corporation, D2L Ltd, D2L Australia Pty Ltd, D2L Europe Ltd, D2L Asia Pte Ltd, D2L India Pvt Ltd, D2L Brasil Soluções de Tecnologia para Educação Ltda and D2L Sistemas de Aprendizaje Innovadores, S. D2 R.L de C.V., and H5P Group AS.

All D2L and H5P marks are owned by the D2L group of companies. Please visit D2L.com/trademarks for a list of D2L marks. All other trademarks are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/d2l-launch-week-highlights-latest-product-releases-302763345.html

SOURCE D2L

Continue Reading

Trending